AlphaYouJA
Insider buying
Jason A Keyes bought $11K of BlossomHill Therapeutics, Inc. (BLSM) stock
Jason A Keyes, Chief Financial Officer of BlossomHill Therapeutics, Inc. (BLSM), bought 700 shares of BLSM stock worth $11K, per an SEC Form 4 filed Aug 10, 2026.
It was an open-market purchase.
The trade happened on Aug 6, 2026, 4 days before it was made public.
- Traded
- Aug 6, 2026
- Disclosed
- Aug 10, 2026
- Filing delay
- 4 days
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More BLSM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.